Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening

Author： Lapan Kirsty A Chapple Joanne P Galcheva-Gargova Zoya Yang Min Tao Jianshi

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.6, Iss.4, 2002-08, pp. : 507-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Navigating tuberculosis drug discovery with target-based screening

By Miller Christopher H O'Toole Ronan F

Expert Opinion on Drug Discovery, Vol. 6, Iss. 8, 2011-08 ,pp. : 839-854

Informa Healthcare

Access to resources Recommend Favorite

Target-Based Drug Discovery for Malaria, Leishmaniasis, and Trypanosomiasis

Current Medicinal Chemistry, Vol. 7, Iss. 8, 2000-08 ,pp. : 835-860

Bentham Science Publishers

Access to resources Recommend Favorite

Applications of Biophysical Tools to Target-Based Discovery of Novel Antibacterial Leads

Current Drug Targets, Vol. 13, Iss. 3, 2012-01 ,pp. : 388-408

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Discovery and Target Validation

Cells Tissues Organs, Vol. 169, Iss. 3, 2001-06 ,pp. : 265-271

Karger

Access to resources Recommend Favorite

Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery

By Sharma Anshika Khuller Gopal K Sharma Sadhna

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 753-765

Informa Healthcare

Access to resources Recommend Favorite